The effects of probenecid on the disposition of risperidone and olanzapine in healthy volunteers

John S. Markowitz, C. Lindsay DeVane, Heidi L. Liston, David W. Boulton, S. Craig Risch

Clinical Pharmacology & Therapeutics · 2002 · 38 citations · 0 references

DOIFull text

Open access

Abstract

Inhibition of uridine diphosphoglucuronate-glucuronosyltransferase appeared to influence the disposition of olanzapine but not risperidone. Phase 2 metabolism may significantly influence the disposition of antipsychotic drugs and may be an important aspect of the variability in metabolism, participation in drug-drug interactions, and clinical response to some antipsychotic agents.